glp 1 and substance use disorder GLP-1 receptor agonists are promising but unproven treatments for alcohol disorders glp-1 alcohol reduction receptor agonists

It has also shown promise in its ability to: Improve spinal cord injury recovery Reduce nerve death and demyelination Reduce symptoms of schizophrenia and protect the brain from harmful agents in animal models [13]

Gao J, Xu Y, Zhang W et al (2024) Transcriptomic insights into the role of PhoP in regulating lipid A modification and efflux-associated genes in Acinetobacter baumannii

Together, these compounds allow researchers to explore overlapping aspects of central nervous system function, including neuropeptide signaling, stress-response modulation, circadian regulation, and the interface between aging biology and neuroendocrine control

Low B12 may result in decreased cognitive function, poor memory, depression, palpitations, and vision changes